Hypertension as a risk factor for ischemic stroke in women

Canadian Journal of Cardiology

Volumn 30, Issue 7, 2014, Pages 774-782

  Gorgui, Jessica ^a   Gorshkov, Maxim ^a   Khan, Nadia ^b   Daskalopoulou, Stella S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; DOSE RESPONSE; ETHNICITY; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MATERNAL HYPERTENSION; MENOPAUSE; META ANALYSIS (TOPIC); PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; REVIEW; RISK FACTOR; RISK REDUCTION; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; BRAIN ISCHEMIA; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; RISK ASSESSMENT; RISK FACTORS; WOMEN'S HEALTH; WORLD HEALTH;

EID: 84902966299     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.01.007     Document Type: Review

References (85)

1. Heart and Stroke Foundation of Canada. Tipping the scales of progress: heart disease and stroke in Canada 2006. Available at: Accessed January 18,2014. http://www.heartandstroke.com/atf/cf/%7B99452D8B-E7F1-4BD6-A57D-B136CE6C95BF%7D/Tipping_the_Scales_new.pdf.
2. Mackay J., Mensah G. The atlas of heart disease and stroke 2004, World Health Organization, Geneva, Switzerland.
3. Folsom A.R., Rosamond W.D., Shahar E., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1999, 100:736-742.
4. O'Donnell M.J., Xavier D., Liu L., et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376:112-123.
5. Tanizaki Y., Kiyohara Y., Kato I., et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000, 31:2616-2622.
6. Kannel W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571-1576.
7. Wilkins K., Campbell N.R., Joffres M.R., et al. Blood pressure in Canadian adults. Health Rep 2010, 21:37-46.
8. Whelton P.K., He J., Appel L.J., et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002, 288:1882-1888.
9. Cook N.R., Cohen J., Hebert P.R., Taylor J.O., Hennekens C.H. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995, 155:701-709.
10. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
11. Lawes C.M., Rodgers A., Bennett D.A., et al. Blood pressure and cardiovascular disease in the Asia Pacific region. JHypertens 2003, 21:707-716.
12. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
13. Woodward M., Tsukinoki-Murakami R., Murakami Y., et al. The epidemiology of stroke amongst women in the Asia-Pacific region. Womens Health (Lond Engl) 2011, 7:305-317.
14. The World Health Report 2002: reducing risks, promoting healthy life 2002, World Health Organisation, World Health Organisation, Geneva, Switzerland.
15. Lawes C.M., Bennett D.A., Feigin V.L., Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004, 35:1024.
16. Hackam D.G., Quinn R.R., Ravani P., et al. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2013, 29:528-542.
17. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
18. Ong K.L., Cheung B.M., Man Y.B., Lau C.P., Lam K.S. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007, 49:69-75.
19. Reeves M.J., Bushnell C.D., Howard G., et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008, 7:915-926.
20. Xing D., Nozell S., Chen Y.F., Hage F., Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol 2009, 29:289-295.
21. Mayo N.E., Nadeau L., Daskalopoulou S.S., Cote R. The evolution of stroke in Quebec: a 15-year perspective. Neurology 2007, 68:1122-1127.
22. Field T.S., Green T.L., Roy K., Pedersen J., Hill M.D. Trends in hospital admission for stroke in Calgary. Can J Neurol Sci 2004, 31:387-393.
23. Rothwell P.M., Coull A.J., Giles M.F., et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004, 363:1925-1933.
24. Petrea R.E., Beiser A.S., Seshadri S., et al. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 2009, 40:1032-1037.
25. Arima H., Tanizaki Y., Yonemoto K., et al. Impact of blood pressure levels on different types of stroke: the Hisayama study. JHypertens 2009, 27:2437-2443.
26. Chambless L.E., Heiss G., Shahar E., Earp M.J., Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. [Erratum appears in Am J Epidemiol 2004;160:927]. Am J Epidemiol 2004, 160:259-269.
27. Ikeda A., Iso H., Yamagishi K., Inoue M., Tsugane S. Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens 2009, 22:273-280.
28. Ishikawa S., Kario K., Kayaba K., et al. Continued high risk of stroke in treated hypertensives in a general population: the Jichi Medical School Cohort study. Hypertens Res 2008, 31:1125-1133.
29. Kikumura T., Omae T., Ueda K. Long-term changes in blood pressure prior to the development of cerebral infarction. The Hisayama study. JChronic Dis 1981, 34:239-248.
30. Lokkegaard E., Jovanovic Z., Heitmann B.L., et al. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study. Arch Neurol 2003, 60:1379-1384.
31. Mannisto T., Mendola P., Vaarasmaki M., et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013, 127:681-690.
32. Martin-Merino E., Ruigomez A., Johansson S., Garcia-Rodriguez L.A. Hospitalised ischaemic cerebrovascular accident and risk factors in a primary care database. Pharmacoepidemiol Drug Saf 2011, 20:1050-1056.
33. Ness J., Aronow W.S., Ahn C. Risk factor for ischemic stroke in older persons in an academic hospital based geriatrics practice. Prev Cardiol 2000, 3:118-120.
34. Pfeffer R.I., Van Den Noort S. Estrogen use and stroke risk in postmenopausal women. Am J Epidemiol 1976, 103:445-456.
35. Rohr J., Kittner S., Feeser B., et al. Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol 1996, 53:603-607.
36. Salonen J.T., Puska P., Tuomilehto J., Homan K. Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland. Stroke 1982, 13:327-333.
37. Seshadri S., Wolf P.A., Beiser A., et al. Elevated midlife blood pressure increases stroke risk in elderly persons: The Framingham study. Arch Intern Med 2001, 161:2343-2350.
38. Shahzad A., Abbasi S., Nasim A., Gul S. Risk factors for first stroke in women less than 50. JPostgrad Med Inst 2009, 23:236-240.
39. Takahashi I., Geyer S.M., Nishi N., et al. Lifetime risk of stroke and impact of hypertension: estimates from the adult health study in Hiroshima and Nagasaki. Hypertens Res 2011, 34:649-654.
40. Ueshima H., Iida M., Shimamoto T., et al. Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. Prev Med 1980, 9:722-740.
41. Rothwell P.M. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010, 375:938-948.
42. Rothwell P.M., Howard S.C., Dolan E., et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010, 375:895-905.
43. Migneco A., Ojetti V., Covino M., et al. Increased blood pressure variability in menopause. Eur Rev Med Pharmacol Sci 2008, 12:89-95.
44. Shimbo D., Newman J.D., Aragaki A.K., et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension 2012, 60:625-630.
45. Neal B., MacMahon S., Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000, 356:1955-1964.
46. Wolf-Maier K., Cooper R.S., Kramer H., et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004, 43:10-17.
47. Gee M.E., Janssen I., Pickett W., et al. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009. Can J Cardiol 2012, 28:367-374.
48. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-209.
49. Rossi A., Dikareva A., Bacon S.L., Daskalopoulou S.S. The impact of physical activity on mortality in patients with high blood pressure: a systematic review. JHypertens 2012, 30:1277-1288.
50. Conen D., Ridker P.M., Buring J.E., Glynn R.J. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. BMJ 2007, 335:432.
51. Mathewson F.A., Corne R.A., Nelson N.A., Hill N.L. Blood pressure characteristics of a select group of North American males, followed for 20 years. Can Med Assoc J 1972, 106:549-557.
52. Miall W.E., Lovell H.G. Relation between change of blood pressure and age. Br Med J 1967, 2:660-664.
53. Lisabeth L., Bushnell C. Stroke risk in women: the role of menopause and hormone therapy. Lancet Neurol 2012, 11:82-91.
54. Murphy S.J., McCullough L.D., Smith J.M. Stroke in the female: role of biological sex and estrogen. ILAR J 2004, 45:147-159.
55. Bath P.M., Gray L.J. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005, 330:342.
56. Mosca L., Benjamin E.J., Berra K., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. JAm Coll Cardiol 2011, 57:1404-1423.
57. Paganini-Hill A. Hormone replacement therapy and stroke: risk, protection or no effect?. Maturitas 2001, 38:243-261.
58. Sare G.M., Gray L.J., Bath P.M. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2008, 29:2031-2041.
59. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003, 289:2673-2684.
60. Brown M.C., Best K.E., Pearce M.S., et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 2013, 28:1-19.
61. McDonald S.D., Malinowski A., Zhou Q., Yusuf S., Devereaux P.J. Cardiovascular sequelae of pre-eclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008, 156:918-930.
62. Mongraw-Chaffin M.L., Cirillo P.M., Cohn B.A. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010, 56:166-171.
63. Fraser A., Nelson S.M., Macdonald-Wallis C., et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 2012, 125:1367-1380.
64. Kaaja R.J., Greer I.A. Manifestations of chronic disease during pregnancy. JAMA 2005, 294:2751-2757.
65. Ehrenthal D.B., Jurkovitz C., Hoffman M., Jiang X., Weintraub W.S. Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertension. JWomens Health (Larchmt) 2011, 20:67-72.
66. Romundstad P.R., Magnussen E.B., Smith G.D., Vatten L.J. Hypertension in pregnancy and later cardiovascular risk: common antecedents?. Circulation 2010, 122:579-584.
67. Seely E.W., Solomon C.G. Insulin resistance and its potential role in pregnancy-induced hypertension. JClin Endocrinol Metab 2003, 88:2393-2398.
68. Hollander M., Koudstaal P.J., Bots M.L., et al. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. JNeurol Neurosurg Psychiatry 2003, 74:317-321.
69. Lewsey J.D., Gillies M., Jhund P.S., et al. Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke 2009, 40:1038-1043.
70. Rothwell P.M., Coull A.J., Silver L.E., et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005, 366:1773-1783.
71. Sealy-Jefferson S., Wing J.J., Sanchez B.N., et al. Age- and ethnic-specific sex differences in stroke risk. Gend Med 2012, 9:121-128.
72. Vega T., Zurriaga O., Ramos J.M., et al. Stroke in Spain: epidemiologic incidence and patterns; a health sentinel network study. JStroke Cerebrovasc Dis 2009, 18:11-16.
73. Kannel W.B., Wolf P.A., Verter J., McNamara P.M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 1970, 214:301-310.
74. Seshadri S., Beiser A., Kelly-Hayes M., et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006, 37:345-350.
75. Ohira T., Shahar E., Chambless L.E., et al. Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 2006, 37:2493-2498.
76. Rosamond W.D., Folsom A.R., Chambless L.E., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999, 30:736-743.
77. Quan H., Chen G., Walker R.L., et al. Incidence, cardiovascular complications and mortality of hypertension by sex and ethnicity. Heart 2013, 99:715-721.
78. Morgenstern L.B., Smith M.A., Lisabeth L.D., et al. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol 2004, 160:376-383.
79. Lisabeth L.D., Smith M.A., Sanchez B.N., Brown D.L. Ethnic disparities in stroke and hypertension among women: the BASIC project. Am J Hypertens 2008, 21:778-783.
80. Mohan S., Chen G., Campbell N.R., Hemmelgarn B.R. Regional variations in not treating diagnosed hypertension in Canada. Can J Cardiol 2010, 26:409-413.
81. Walker R.L., Chen G., Campbell N.R., et al. Canadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006. Can J Cardiol 2011, 27:461-467.
82. Wassertheil-Smoller S., Anderson G., Psaty B.M., et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 2000, 36:780-789.
83. Giralt D., Domingues-Montanari S., Mendioroz M., et al. The gender gap in stroke: a meta-analysis. Acta Neurol Scand 2012, 125:83-90.
84. Zuo W., Zhang W., Chen N.H. Sexual dimorphism in cerebral ischemia injury. Eur J Pharmacol 2013, 711:73-79.
85. Nuzzo A., Rossi R., Modena M.G. Endothelial dysfunction in postmenopausal women and hypertension. Womens Health (Lond Engl) 2007, 3:515-518.